Scholarlink

Background <p><i>Aggregatibacter aphrophilus</i> is a normal commensal of the human oropharynx and a member of the HACEK group of organisms. This microorganism can cause a wide variety of infections mainly including endocarditis and osteoarticular infections. However, empyema thoracis caused by <i>A. aphrophilus</i> is very rare. The information about this rare disease is very limited. We herein report 2 rare cases having empyema thoracis due to <i>A. aphrophilus</i>.</p> Case presentation <p>An 88-year-old man with a history of bronchiectasis and periodontitis was admitted for a 2-week history of right lower chest pain, a low-grade fever, and productive cough. Another 51-year-old man with a history of alcoholic liver cirrhosis was admitted with complaint of right chest pain for one week. The cultures of the pleural effusion in both cases were positive for <i>A. aphrophilus</i> which was confirmed by the matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). The former case responded to a 2-week course of intravenous piperacillin/tazobactam. The latter case died from shock and progressive deterioration of liver function.</p> Conclusions <p>The effective treatment of&#xa0;<i>A. aphrophilus</i> empyema thoracis should comprise (i) accurate causative pathogen identification by <i>conforming with</i> MALDI-TOF MS<i>,</i> (ii) adequate empyema drainage, (iii) appropriate antimicrobial therapy with penicillin/β-lactam inhibitor combinations or the third-generation cephalosporins, and (iv) underlying diseases management especially malignancy and alcoholism.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Empyema thoracis caused by Aggregatibacter aphrophilus: two cases report

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月2日

查看全文
  • Deng-Wei Chou,
  • Chao-Tai Lee,
  • Shu-Ling Wu

摘要

Background

Aggregatibacter aphrophilus is a normal commensal of the human oropharynx and a member of the HACEK group of organisms. This microorganism can cause a wide variety of infections mainly including endocarditis and osteoarticular infections. However, empyema thoracis caused by A. aphrophilus is very rare. The information about this rare disease is very limited. We herein report 2 rare cases having empyema thoracis due to A. aphrophilus.

Case presentation

An 88-year-old man with a history of bronchiectasis and periodontitis was admitted for a 2-week history of right lower chest pain, a low-grade fever, and productive cough. Another 51-year-old man with a history of alcoholic liver cirrhosis was admitted with complaint of right chest pain for one week. The cultures of the pleural effusion in both cases were positive for A. aphrophilus which was confirmed by the matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). The former case responded to a 2-week course of intravenous piperacillin/tazobactam. The latter case died from shock and progressive deterioration of liver function.

Conclusions

The effective treatment of A. aphrophilus empyema thoracis should comprise (i) accurate causative pathogen identification by conforming with MALDI-TOF MS, (ii) adequate empyema drainage, (iii) appropriate antimicrobial therapy with penicillin/β-lactam inhibitor combinations or the third-generation cephalosporins, and (iv) underlying diseases management especially malignancy and alcoholism.